SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-001897
Filing Date
2017-01-13
Accepted
2017-01-13 16:47:38
Documents
1
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 doc1.html 5  
1 FORM 5 doc1.xml 5 4768
  Complete submission text file 0001140361-17-001897.txt   6320
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O SANGAMO BIOSCIENCES IN STE.A-100 POINT RICHMOND TECH CENTER 501 CANA BLVD RICHMOND CA 94804
Business Address
LANPHIER EDWARD O II (Reporting) CIK: 0001234386 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-30171 | Film No.: 17528360